4.6 Article

Alaska Native smokers and smokeless tobacco users with slower CYP2A6 activity have lower tobacco consumption, lower tobacco-specific nitrosamine exposure and lower tobacco-specific nitrosamine bioactivation

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Oncology

Exposure to Nicotine and Carcinogens among Southwestern Alaskan Native Cigarette Smokers and Smokeless Tobacco Users

Neal L. Benowitz et al.

CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2012)

Article Biotechnology & Applied Microbiology

CYP2A6 and CYP2B6 genetic variation and its association with nicotine metabolism in South Western Alaska Native people

Matthew J. Binnington et al.

PHARMACOGENETICS AND GENOMICS (2012)

Article Oncology

Relationship Between CYP2A6 and CHRNA5-CHRNA3-CHRNB4 Variation and Smoking Behaviors and Lung Cancer Risk

Catherine A. Wassenaar et al.

JOURNAL OF THE NATIONAL CANCER INSTITUTE (2011)

Article Oncology

Urine Menthol as a Biomarker of Mentholated Cigarette Smoking

Neal L. Benowitz et al.

CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2010)

Article Pharmacology & Pharmacy

Genetic Variation in Nicotine Metabolism Predicts the Efficacy of Extended-Duration Transdermal Nicotine Therapy

C. Lerman et al.

CLINICAL PHARMACOLOGY & THERAPEUTICS (2010)

Article Pharmacology & Pharmacy

Hepatic CYP2A6 levels and nicotine metabolism: impact of genetic, physiological, environmental, and epigenetic factors

Nael Al Koudsi et al.

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2010)

Article Genetics & Heredity

Sequence variants at CHRNB3-CHRNA6 and CYP2A6 affect smoking behavior

Thorgeir E. Thorgeirsson et al.

NATURE GENETICS (2010)

Article Oncology

Utility and Relationships of Biomarkers of Smoking in African-American Light Smokers

Man Ki Ho et al.

CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2009)

Article Oncology

Elimination Kinetics of the Tobacco-Specific Biomarker and Lung Carcinogen 4-(Methylnitrosamino)-1-(3-Pyridyl)-1-Butanol

Maciej L. Goniewicz et al.

CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2009)

Review Pharmacology & Pharmacy

CYP2A6 polymorphisms and risk for tobacco-related cancers

Ana Rossini et al.

PHARMACOGENOMICS (2008)

Review Pharmacology & Pharmacy

Genetic variability in CYP2A6 and the pharmacokinetics of nicotine

Jill C. Mwenifiumbo et al.

PHARMACOGENOMICS (2007)

Article Medicine, Legal

Relationship between machine-derived smoke yields and biomarkers in cigarette smokers in Germany

Gerhard Scherer et al.

REGULATORY TOXICOLOGY AND PHARMACOLOGY (2007)

Article Substance Abuse

An association of CYP2A6 genotype and smoking topography

Andrew A. Strasser et al.

NICOTINE & TOBACCO RESEARCH (2007)

Article Pharmacology & Pharmacy

CYP2A6 genotype and the metabolism and disposition kinetics of nicotine

Neal L. Benowitz et al.

CLINICAL PHARMACOLOGY & THERAPEUTICS (2006)

Article Public, Environmental & Occupational Health

Iqmik: A form of smokeless tobacco used among Alaska natives

CC Renner et al.

AMERICAN JOURNAL OF HEALTH BEHAVIOR (2005)

Article Biotechnology & Applied Microbiology

Ethnic variation in CYP2A6*7, CYP2A6*8 and CYP2A6*10 as assessed with a novel haplotyping method

JC Mwenifumbo et al.

PHARMACOGENETICS AND GENOMICS (2005)

Article Pharmacology & Pharmacy

Nicotine metabolite ratio as an index of cytochrome P450 2A6 metabolic activity

D Dempsey et al.

CLINICAL PHARMACOLOGY & THERAPEUTICS (2004)